Government Research Support

In this era of mounting deficits, we struggle to find extravagances whose elimination is practicable and effective. Among the many proposals to salvage the economy is imposition of a drastic reduction of the government support of basic research. Proponents of these austerities view research activity as frivolous-its practitioners in the laboratories as misty-eyed, impractical dreamers who are wholly out of touch with reality and the serious needs of our society. The administration favors diver

Written byWells Farnsworth
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In this era of mounting deficits, we struggle to find extravagances whose elimination is practicable and effective.

Among the many proposals to salvage the economy is imposition of a drastic reduction of the government support of basic research. Proponents of these austerities view research activity as frivolous-its practitioners in the laboratories as misty-eyed, impractical dreamers who are wholly out of touch with reality and the serious needs of our society. The administration favors diverting our limited research dollars to projects of the Commerce Department and the Environmental Protection Agency, although the National Academy of Sciences views these projects to be of inferior scientific merit and to lack any peer review (H. Miller, The Scientist, May 27, 1996, page 10).

While the opponents acknowledge that the United States is still preeminent in scientific stature and that we must win the wars on cancer, heart disease, and AIDS now, they are either ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies